内分泌学
内科学
甾醇调节元件结合蛋白
低密度脂蛋白受体
甲状腺激素受体
甲状腺激素受体β
胆固醇
激素
甾醇
核受体
受体
肝X受体
甲状腺激素受体α
甲状腺
低密度脂蛋白
脂蛋白
生物
激素受体
化学
医学
生物化学
转录因子
基因
癌症
乳腺癌
作者
Dong-Ju Shin,Timothy F. Osborne
标识
DOI:10.1074/jbc.m305417200
摘要
High affinity uptake of serum-derived low density lipoprotein (LDL) cholesterol is accomplished through the LDL receptor in the liver. In mammals, thyroid hormone depletion leads to decreased LDL receptor expression and elevated serum cholesterol. The clinical association in humans has been known since the 1920s; however, a molecular explanation has been lacking. LDL receptor levels are subject to negative feedback regulation by cellular cholesterol through sterol regulatory element-binding protein-2 (SREBP-2). Here we demonstrate that the SREBP-2 gene is regulated by thyroid hormone and that increased SREBP-2 nuclear protein levels in hypothyroid animals results in thyroid hormone-independent activation of LDL receptor gene expression and reversal of the associated hypercholesterolemia. This occurs without effects on other thyroid hormone-regulated genes. Thus, we propose that the decreased LDL receptor and increased serum cholesterol associated with hypothyroidism are secondary to the thyroid hormone effects on SREBP-2. These results suggest that hypercholesterolemia associated with hypothyroidism can be reversed by agents that directly increase SREBP-2. Additionally, these results indicate that mutations or drugs that lower nuclear SREBP-2 would cause hypercholesterolemia.
科研通智能强力驱动
Strongly Powered by AbleSci AI